AGC Inc.

Equities

5201

JP3112000009

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-02-18 am EST			5-day change	1st Jan Change
6,365.00 ^JPY	-0.06%		+2.04%	+22.57%

Feb. 06	AGC Returns to Profitability in Nine-Months Ended Dec. 31,2025	MT
Feb. 06	AGC Inc., 2025 Earnings Call, Feb 06, 2026

Transcript : AGC Inc. - Special Call

Published on 09/26/2025 at 04:50 am EDT - Modified on 09/26/2025 at 06:35 am EDT

S&P Capital IQ

Presenter Speech
Kazumi Tamaki (Executives)

It's time to begin the ESG briefing by AGC. My name is Tamaki, via IR, master of the ceremony today. Thank you for this opportunity. Let me introduce today's

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about AGC Inc.

Feb. 06	AGC Returns to Profitability in Nine-Months Ended Dec. 31,2025	MT
Feb. 06	AGC Inc., 2025 Earnings Call, Feb 06, 2026
Feb. 05	AGC Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Feb. 05	AGC Inc. Declares Year End Dividend for the Fiscal Year Ended December 31, 2025; Provides Dividend Guidance for the Second Quarter End and Year End of Fiscal Year Ending December 31, 2026	CI
Feb. 05	AGC Inc. Provides Consolidated Earnings Guidance for the First Half Ending June 30, 2026 and Fiscal Year Ending December 31, 2026	CI
Jan. 27	SBI Securities Starts AGC at Buy with 6,700 Yen Price Target	MT
Dec. 21	Dai Nippon Toryo Company, Limited completed the acquisition of remaining 90% stake in Agc Coat-Tech Co., Ltd. from AGC Inc..	CI
Dec. 09	AGC Names CFO	MT
Dec. 08	AGC Inc. Announces Resignation of Shinji Miyaji as CFO, Effective as of March 27, 2026	CI
Dec. 08	Agc Inc. Announces Changes in the Members of the Board of Directors, Audit & Supervisory Board and Executive Officers, Effective March 27, 2026	CI
Dec. 08	Shinji Miyaji to Resign as Director and Senior Executive Vice President of AGC Inc. in March 2026	CI
Dec. 02	Agc Biologics Partners with Atum to Accelerate Timelines for Cell Line Development	CI
Nov. 19	AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality	CI
Nov. 05	AGC Inc. Announces CFO Changes, Effective January 1, 2026	CI
Nov. 05	AGC Inc. Announces Management Changes, Effective January 1, 2026	CI